Skip to content

Effects of transcutaneous electrical acupoint stimulation (TEAS) on postoperative pain in patients with gastric and esophageal ESD surgery

Effects of transcutaneous electrical acupoint stimulation (TEAS) on postoperative pain in patients with gastric and esophageal ESD surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052837
Enrollment
Unknown
Registered
2021-11-06
Start date
2021-11-22
Completion date
Unknown
Last updated
2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after gastric and esophageal ESD surgery

Interventions

experimental group:TEAS (transcutaneous electrical acupoint stimulation)

Sponsors

Beijing Friendship Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years, diagnosed with stomach and esophagus tumors, patients undergoing ESD surgery, gender is not limited; 2. 18 kg/m^2 <= BMI <= 30 kg/m^2; 3. ASA (American Society of Anesthesiologists) I-III; 4. Voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. There are surgical incisions or surgical scars in the meridians of Hegu/Neiguan/Shangjuxu/Zusanli; 2. Patients with skin infections in the acupoints; 3. Patients with upper or lower limb nerve damage; 4. Patients who have participated in other clinical trials in the past four weeks; 5. Patients who do not understand VAS scores and NRS scores and cannot be graded; 6. Applying a pacemaker patient; 7. Pregnant women, maternal, and urine pregnancy test positive patients; 8. Patients with combined pain before surgery, patients who are taking central analgesic drugs, opioid addiction, dependents; 9. Preoperative combination of severe central nervous system diseases and severe mental illness; 10. Patients considered by the investigator to be unfit to participate in the study.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale (VAS);

Secondary

MeasureTime frame
Calm rating;Nausea and vomiting scores;Time to first flatus;Time to want to eat;Length of hospital stay;Hospitalization expenses;Postoperative clinical complications (such as vomiting, fever, pneumonia, wound infection, and bleeding);Chill ratings;

Countries

China

Contacts

Public ContactAn Lixin

Beijing Friendship Hospital

anlixin8120@163.com+86 13810248120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026